Indaptus Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Indaptus Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Indaptus Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $54.5M, a 4.83% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $54.5M +$2.51M +4.83% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $52M -$1.49M -2.78% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $53.5M +$51.2M +2287% Dec 31, 2021 10-K 2023-03-17
Q4 2020 $2.24M Dec 31, 2020 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.